Evidence map›Paper›PMID 28944955›Full record

Observational studyHealth services research2018

Trends in Use of Risk-Reducing Mastectomy in a Context of Celebrity Decisions and Media Coverage: An Observational Study in the United States and Australia.

Jialin Mao, Louisa Jorm, Art Sedrakyan

Abstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Health services research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. EBCC-13 manifesto: Balancing pros and cons for contralateral prophylactic mastectomy.European journal of cancer (Oxford, England : 1990) · 2023
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jialin MaoDepartment of Healthcare Policy and Research, Weill Cornell Medical College, New York, NY.ORCID 0000-0001-6671-3474
Louisa JormCenter for Big Data Research in Health, University of New South Wales, Sydney, NSW, Australia.
Art SedrakyanDepartment of Healthcare Policy and Research, Weill Cornell Medical College, New York, NY.

Funding

Creating National Surveillance Infrastructure for Priority Medical DevicesU01FD005478 · FDA · WEILL MEDICAL COLL OF CORNELL UNIV · PI SEDRAKYAN, ART · 2015 to 2019
$6.5M
FDA HHS U01 FD005478
6 · The paper itself

Abstract

objectiveTo examine trends in risk-reducing mastectomy (RRM) and immediate breast reconstruction in New York State and New South Wales, especially before and after Angelina Jolie's announcement of her surgery in 2013. DATA SOURCE: Hospital discharge data, 2004-2014. STUDY

designTrends in procedures were assessed using Poisson regression and the Cochrane-Armitage test. DATA EXTRACTION

methodsExtracted using procedure codes. PRINCIPAL

findingsThere was an increase in RRM procedures after May 2013 in both regions, with a peak during late 2013-early 2014. The average bimonthly RRM procedures were significantly higher after Jolie's announcement than before.

conclusionsIn both countries, we found a substantial increase of RRM after Jolie's announcement, highlighting the impact of celebrity health care coverage on preventive surgical choice and the need for decision aids to assist patients.

Indexed as

Risk Reduction BehaviorAdolescentAdultAgedAged, 80 and overAge FactorsBRCA1 ProteinBreast NeoplasmsFemaleHumansMammaplastyMass MediaMastectomyMiddle AgedNew South WalesNew YorkBRCA1 ProteinBRCA1 protein, humanbreast cancer preventioncelebrity effectRisk-reducing mastectomy

Identifiers

PMID28944955
PMCPMC6056602

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.